24 May 2013
Keywords: pharmacopeia, licenses, b-ms, dara, portfolio, entered, exclusive
Article | 10 April 2006
Pharmacopeia has entered an exclusive licensing deal with fellow US firm Bristol-Myers Squibb for worldwide development and commercialization rights to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.